277
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant

, , , , &
Pages 184-193 | Received 20 May 2019, Accepted 19 Sep 2019, Published online: 08 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jack Donlon, Pooja Kumari, Sajoy P. Varghese, Michael Bai, Ori David Florentin, Emma D. Frost, John Banks, Niyathi Vadlapatla, Olivia Kam, Mujeeb U. Shad, Shafiqur Rahman, Osama A. Abulseoud, Trevor W. Stone & Maju Mathew Koola. (2024) Integrative Pharmacology in the Treatment of Substance Use Disorders. Journal of Dual Diagnosis 20:2, pages 132-177.
Read now

Articles from other publishers (9)

Nicolas Marie & Florence Noble. (2024) Pistes actuelles d’expérimentations pharmacologiques dans le traitement de la dépendance à la cocaïne. Psychotropes Vol. 29:4, pages 105-121.
Crossref
Carla Carnovale, Cristiana Perrotta, Sara Baldelli, Dario Cattaneo, Cristina Montrasio, Silvia S Barbieri, Giulio Pompilio, Chiara Vantaggiato, Emilio Clementi & Marco Pozzi. (2023) Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovascular Research 119:3, pages 647-667.
Crossref
Anthony M. Downs & Zoe A. McElligott. (2022) Noradrenergic circuits and signaling in substance use disorders. Neuropharmacology 208, pages 108997.
Crossref
Annika M. A. Berends, Mathieu S. Bolhuis, Ilja M. Nolte, Edward Buitenwerf, Thera P. Links, Henri J. L. M. Timmers, Richard A. Feelders, Elisabeth M. W. Eekhoff, Eleonora P. M. Corssmit, Peter H. Bisschop, Harm R. Haak, Ron H. N. van Schaik, Samira el Bouazzaoui, Bob Wilffert & Michiel N. Kerstens. (2022) Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients. Biomedicines 10:4, pages 896.
Crossref
Hasti Hadizadeh, Jose Flores, Eric Nunes, Talia Mayerson, Marc N. Potenza & Gustavo A. Angarita. (2022) Novel Pharmacological Agents for the Treatment of Cocaine Use Disorder. Current Behavioral Neuroscience Reports 9:1, pages 27-46.
Crossref
Noèlia Fernàndez-Castillo, Judit Cabana-Domínguez, Roser Corominas & Bru Cormand. (2021) Molecular genetics of cocaine use disorders in humans. Molecular Psychiatry 27:1, pages 624-639.
Crossref
Katarzyna Kucwaj-Brysz, Anna Dela, Sabina Podlewska, Marek Bednarski, Agata Siwek, Grzegorz Satała, Kinga Czarnota, Jadwiga Handzlik & Katarzyna Kieć-Kononowicz. (2021) The Structural Determinants for α1-Adrenergic/Serotonin Receptors Activity among Phenylpiperazine-Hydantoin Derivatives. Molecules 26:22, pages 7025.
Crossref
Laura Brandt, Thomas Chao, Sandra D. Comer & Frances R. Levin. (2020) Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction 116:4, pages 694-710.
Crossref
Luigia Rossi, Francesca Pierigè, Marco Agostini, Noemi Bigini, Veronica Termopoli, Yingting Cai, Fang Zheng, Chang-Guo Zhan, Donald W. Landry & Mauro Magnani. (2020) Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells. Frontiers in Physiology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.